Supplemental Fig.S2. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Tongzheng Liu,Yuan Fang,Haoxing Zhang,Min Deng,Bowen Gao,Nifang Niu,Jia Yu,SeungBaek Lee,JungJin Kim,Bo Qin,Fang Xie,Debra Evans,Liewei Wang,Wenhui Lou,Zhenkun Lou

DOI: https://doi.org/10.1158/0008-5472.22409685

2023-01-01

Abstract:Supplemental Fig.S2. HEATR1 regulates cancer cell response to chemotherapy and cell growth

What problem does this paper attempt to address?

Supplemental Fig.S.3 from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Tongzheng Liu,Yuan Fang,Haoxing Zhang,Min Deng,Bowen Gao,Nifang Niu,Jia Yu,SeungBaek Lee,JungJin Kim,Bo Qin,Fang Xie,Debra Evans,Liewei Wang,Wenhui Lou,Zhenkun Lou

DOI: https://doi.org/10.1158/0008-5472.22409694.v1

2023-01-01

Abstract:HEATR1 colocalized with Akt and regulates Akt phosphorylation independent of PDK1
Supplemental Fig.S4. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Tongzheng Liu,Yuan Fang,Haoxing Zhang,Min Deng,Bowen Gao,Nifang Niu,Jia Yu,SeungBaek Lee,JungJin Kim,Bo Qin,Fang Xie,Debra Evans,Liewei Wang,Wenhui Lou,Zhenkun Lou

DOI: https://doi.org/10.1158/0008-5472.22409682

2023-01-01

Abstract:Supplemental Fig.S4. Akt inhibitor sensitizes pancreatic tumors with HEATR1 knockdown to gemcitabine.
Supplemental Fig.S.5. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Tongzheng Liu,Yuan Fang,Haoxing Zhang,Min Deng,Bowen Gao,Nifang Niu,Jia Yu,SeungBaek Lee,JungJin Kim,Bo Qin,Fang Xie,Debra Evans,Liewei Wang,Wenhui Lou,Zhenkun Lou

DOI: https://doi.org/10.1158/0008-5472.22409691.v1

2023-01-01

Abstract:Representative strong and weak staining of HEATR1 in pancreatic ductal adenocarcinoma.
Supplemental Data from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Tongzheng Liu,Yuan Fang,Haoxing Zhang,Min Deng,Bowen Gao,Nifang Niu,Jia Yu,SeungBaek Lee,JungJin Kim,Bo Qin,Fang Xie,Debra Evans,Liewei Wang,Wenhui Lou,Zhenkun Lou

DOI: https://doi.org/10.1158/0008-5472.22409697.v1

2023-01-01

Abstract:Supplemental data includes supplement materials, methods and data
HEATR1 Deficiency Promotes Chemoresistance Via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer

Yuan Fang,Xu Han,Jianang Li,Tiantao Kuang,Wenhui Lou

DOI: https://doi.org/10.1155/2020/3181596

IF: 4.501

2020-01-01

Journal of Oncology

Abstract:Objective To discover the correlated gene with HEATR1 in regulating chemoresistance of gemcitabine. Methods Gene chip analysis was performed to find out differential genes between HEATR1-KD and control groups. The top 20 genes were subjected to high-content screening, and functional assay was implemented. Gene expression profiling was carried out to find the downstream target. Immunohistochemistry and survival analysis were performed. Results ZNF185 fold change (4.5285) was the most significant between the HEATR1-KD and control groups. Knocking down ZNF185 could promote the chemosensitivity, apoptosis, and proliferative inhibition, with SMAD4 significantly upregulated. Patients with high HEATR1 and SMAD4 or low ZNF185 exhibited better survival. Conclusion HEATR1, ZNF185, and SMAD4 could affect the chemosensitivity of gemcitabine and may be the indicators of gemcitabine selection in the chemotherapy of pancreatic cancer.
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Wenhua Sang,Yiduo Zhou,Haiyan Chen,Chengxuan Yu,Lisi Dai,Zhongkun Liu,Lang Chen,Yimin Fang,Panpan Ma,Xiangji Wu,Hao Kong,Wenting Liao,Hong Jiang,Junbin Qian,Da Wang,Yun-Hua Liu

DOI: https://doi.org/10.1158/2159-8290.25191539

2024-01-01

Abstract:Supplementary Table S2. Detailed information of human pancreatic tissue array.
Supplementary Figure 5 from Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair

Dongping Wei,Leslie A. Parsels,David Karnak,Mary A. Davis,Joshua D. Parsels,Amanda C. Marsh,Lili Zhao,Jonathan Maybaum,Theodore S. Lawrence,Yi Sun,Meredith A. Morgan

DOI: https://doi.org/10.1158/1078-0432.22450100

2023-01-01

Abstract:PDF file - 52K, LB100 causes an increase in pHistone H3 positive cells.
Figure S3 from P38γ MAPK is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis

Fang Wang,Xiaomei Qi,Ryan Wertz,Matthew Mortensen,Catherine Hagen,John Evans,Yuri Sheinin,Mark James,Pengyuan Liu,Susan Tsai,James D. Thomas,Alexander C. Mackinnon,Michael B. Dwinell,Charles R. Myers,Ramón Bartrons,Liwu Fu,Guan Chen

DOI: https://doi.org/10.1158/0008-5472.22423431.v1

2023-01-01

Abstract:Figure S3. Pancreatic p38ÃƒÅ½Ã,Â³ KO inhibits pancreatic cancer metastasis and decreases p-PFKFB3, PFKFB3, GLUT2, inflammatory cytokine expression and suppresses metabolic and other pancreatic cancer pathways in metastatic and/or primary Pdac.
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Wenhua Sang,Yiduo Zhou,Haiyan Chen,Chengxuan Yu,Lisi Dai,Zhongkun Liu,Lang Chen,Yimin Fang,Panpan Ma,Xiangji Wu,Hao Kong,Wenting Liao,Hong Jiang,Junbin Qian,Da Wang,Yun-Hua Liu

DOI: https://doi.org/10.1158/2159-8290.25183960

2024-01-01

Abstract:Supplementary Table S4. Primers used for qPCR or generating knockout/knockdown constructs.
Supplemental Figure S5 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Ye Tian,Vincent W. S. Wong,Grace L.H. Wong,Weiqin Yang,Hanyong Sun,Jiayun Shen,Joanna H.M. Tong,Minnie Y.Y. Go,Yu-San Cheung,Paul B.S. Lai,Mi Zhou,Gang Xu,Tim H.‐M. Huang,Yuanyuan Wang,Ka Fai To,Alfred S.L. Cheng,Henry Lik‐Yuen Chan

DOI: https://doi.org/10.1158/0008-5472.22412076

2023-01-01

Abstract:HDAC8 promotes growth and inhibits apoptosis of HCC cells.
Supplementary Fig. S5 from FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis

Dan Su,Ruobing Wang,Guangyu Chen,Chen Ding,Yueze Liu,Jinxin Tao,Yuanyang Wang,Jiangdong Qiu,Wenhao Luo,Guihu Weng,Gang Yang,Taiping Zhang

DOI: https://doi.org/10.1158/0008-5472.26711161.v1

2024-01-01

Abstract:Supplementary Fig. S5
Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties

Tao Qin,Ke Chen,Jie Li,Weikun Qian,Ying Xiao,Erxi Wu,Jiguang Ma,Zheling Chen,Zheng Wang,Qingyong Ma,Zheng Wu

DOI: https://doi.org/10.1016/j.biopha.2022.112713

2022-04-01

Abstract:Pancreatic cancer is a fatal disease with poor prognosis. Gemcitabine has been regarded as the mainstay of chemotherapy for pancreatic cancer; however, it is accompanied with a high rate of chemoresistance. Cancer stem cells (CSCs) are characterized by resistance to traditional chemo- and radiotherapies. We have previously reported that heat shock factor 1 (HSF1) is involved in the invasion and metastasis of pancreatic cancer, a highly conserved transcriptional factor that mediates the canonical proteotoxic stress response. Here, we investigate whether HSF1 contributes to the chemoresistance of pancreatic cancer cells caused by gemcitabine and explore the underlying mechanisms. Genetically engineered mice (LSL-KrasG12D/+; Trp53fl/+; Pdx1-Cre mice), which spontaneously develop pancreatic cancer, were used to examine the sensitivity of pancreatic cancer to gemcitabine in vivo. We found that HSF1 was enriched in sphere-forming cancer cells. Panc-1 and MiaPaCa-2 cells treated chronically with gemcitabine displayed increased transcription and expression of CSC-associated markers. In addition, gemcitabine-surviving Panc-1 and MiaPaCa-2 cells showed an increased ability to form tumorspheres. Moreover, we observed that gemcitabine treatment increased the activity and expression of HSF1, as well as transcription of its downstream targets. Finally, HSF1 inhibition significantly suppressed the expression of CSC-associated markers, augmented the cancer-killing property of gemcitabine, and increased chemosensitivity to gemcitabine in vivo. Our study reveals a novel mechanism in which HSF1 promotes the chemoresistance of pancreatic cancer to gemcitabine by modulating CSC-like properties. Targeting HSF1 could be thus a rational strategy to improve treatment outcomes.

pharmacology & pharmacy,medicine, research & experimental
Molecular chaperone HspB2 inhibited pancreatic cancer cell proliferation via activating p53 downstream gene RPRM, BAI1, and TSAP6

Ze Yu,Hao Wang,Yilin Fang,Liangliang Lu,Minghao Li,Bingru Yan,Yuzhe Nie,Chunbo Teng

DOI: https://doi.org/10.1002/jcb.29455

2019-11-06

Journal of Cellular Biochemistry

Abstract:Heat shock proteins (HSPs) were known as the molecular chaperones, which play a pivotal role in the protein quality control system, ensuring correct folding of proteins, and facilitating the correct refolding of damaged proteins via the transient interaction with their substrate proteins. They also practice in the regulation of cell cycles and are involved in apoptosis. We found that HspB2 was almost completely silent in pancreatic cancer and few studies investigated the role of HspB2 in cancer cells, particularly in pancreatic cancer. Here, we reported that HspB2 effectively inhibited cell proliferation in Panc‐1 cells. Specifically, we demonstrated that HspB2 could combine mut‐p53 and change the DNA binding site of mutant p53, subsequently upregulated the expression of RPRM, BAI‐1, and TSAP6 which were the downstream genes of wt‐p53, participate in mediating downstream responses to p53, including inhibiting cell proliferation and angiogenesis. The main aim of this study is to investigate the relationship between HspB2 and p53, and provide a novel treatment strategy for pancreatic cancer.

cell biology,biochemistry & molecular biology
Supplementary Figure 2 from secreted Protein Acidic and Rich in Cysteines-like 1 Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers

Hanguang Hu,Hang Zhang,Weiting Ge,Xiyong Liu,Sofia Loera,Peiguo Chu,Huarong Chen,Jiaping Peng,Lili Zhou,Yu Shibata,Yibin Ying,Suzhan Zhang,Lily Lai,Yun Yen,Shusen Zheng

DOI: https://doi.org/10.1158/1078-0432.22455675

2023-01-01

Abstract:PDF file, 38K, Study design.
Figure S2 from ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer

Yun-Han Huang,Jing Hu,Fei Chen,Nicolas Lecomte,Harihar Basnet,Charles J. David,Matthew D. Witkin,Peter J. Allen,Steven D. Leach,Travis J. Hollmann,Christine A. Iacobuzio-Donahue,Joan Massagué

DOI: https://doi.org/10.1158/2159-8290.22535543.v1

2023-01-01

Abstract:Figure S2
Supplemental Figure S2 from Nicotine Reduces Survival Via Augmentation of Paracrine HGF–MET Signaling in the Pancreatic Cancer Microenvironment

Daniel Delitto,Dongyu Zhang,Song Han,Brian S. Black,Andrea E. Knowlton,Adrian C. Vlada,George A. Sarosi,Kevin E. Behrns,Ryan M. Thomas,Xinzheng Lu,Chen Liu,Thomas J. George,Steven Hughes,Shannon M. Wallet,José G. Treviño

DOI: https://doi.org/10.1158/1078-0432.22458260.v1

2023-01-01

Abstract:Supplemental Figure S2. Nicotine-mediated induction of c-Met is Src-dependent.
Supplementary Figure 4 from Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

Carl G. Engelke,Leslie A. Parsels,Yushen Qian,Qiang Zhang,David Karnak,Jordan R. Robertson,Daria M. Tanska,Dongping Wei,Mary A. Davis,Joshua D. Parsels,Lili Zhao,Joel K. Greenson,Theodore S. Lawrence,Jonathan Maybaum,Meredith A. Morgan

DOI: https://doi.org/10.1158/1078-0432.22446756.v1

2023-01-01

Abstract:PDF file, 116K, Animal weight during treatment with MK8776, gemcitabine, and radiation.
Supplementary Figure 2 from PTEN Loss Accelerates KrasG12D-Induced Pancreatic Cancer Development

Reginald Hill,Joseph Hargan Calvopina,Christine Kim,Ying Wang,David W. Dawson,Timothy R. Donahue,Sarah Dry,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22385247

2023-01-01

Abstract:Supplementary Figure 2 from PTEN Loss Accelerates KrasG12D-Induced Pancreatic Cancer Development
Supplementary Figure S6 from HER2/EGFR–AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer

Fei Huang,Qiaoni Shi,Yuzhen Li,Linlin Xu,Chi Xu,Fenfang Chen,Hai Wang,Hongwei Liao,Zai Chang,Fang Liu,Xiang H.-F. Zhang,Xin-Hua Feng,Jing-Dong J. Han,Shiwen Luo,Ye-Guang Chen

DOI: https://doi.org/10.1158/0008-5472.22420265

2023-01-01

Abstract:S208 phosphorylation is important for Smad3 nuclear accumulation
Supplementary Figure 7 from Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

Carl G. Engelke,Leslie A. Parsels,Yushen Qian,Qiang Zhang,David Karnak,Jordan R. Robertson,Daria M. Tanska,Dongping Wei,Mary A. Davis,Joshua D. Parsels,Lili Zhao,Joel K. Greenson,Theodore S. Lawrence,Jonathan Maybaum,Meredith A. Morgan

DOI: https://doi.org/10.1158/1078-0432.22446747

2023-01-01

Abstract:PDF file, 297K, Phosphorylated Chk1 (S345) in MiaPaCa-2 xenograft slices.

Supplemental Fig.S2. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplemental Fig.S.3 from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplemental Fig.S4. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplemental Fig.S.5. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplemental Data from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

HEATR1 Deficiency Promotes Chemoresistance Via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer

Supplementary Table S2 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Supplementary Figure 5 from Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair

Figure S3 from P38γ MAPK is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis

Supplementary Table S4 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Supplemental Figure S5 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Supplementary Fig. S5 from FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis

Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties

Molecular chaperone HspB2 inhibited pancreatic cancer cell proliferation via activating p53 downstream gene RPRM, BAI1, and TSAP6

Supplementary Figure 2 from <i>secreted Protein Acidic and Rich in Cysteines-like 1</i> Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers

Figure S2 from ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer

Supplemental Figure S2 from Nicotine Reduces Survival Via Augmentation of Paracrine HGF–MET Signaling in the Pancreatic Cancer Microenvironment

Supplementary Figure 4 from Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

Supplementary Figure 2 from PTEN Loss Accelerates <i>Kras</i><sup><i>G12D</i></sup>-Induced Pancreatic Cancer Development

Supplementary Figure S6 from HER2/EGFR–AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer

Supplementary Figure 7 from Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

Supplemental Fig.S2. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplemental Fig.S.3 from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplemental Fig.S4. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplemental Fig.S.5. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplemental Data from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

HEATR1 Deficiency Promotes Chemoresistance Via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer

Supplementary Table S2 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Supplementary Figure 5 from Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair

Figure S3 from P38γ MAPK is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis

Supplementary Table S4 from Receptor-interacting Protein Kinase 2 is an Immunotherapy Target in Pancreatic Cancer

Supplemental Figure S5 from Histone Deacetylase HDAC8 Promotes Insulin Resistance and Β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma

Supplementary Fig. S5 from FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis

Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties

Molecular chaperone HspB2 inhibited pancreatic cancer cell proliferation via activating p53 downstream gene RPRM, BAI1, and TSAP6

Supplementary Figure 2 from &lt;i&gt;secreted Protein Acidic and Rich in Cysteines-like 1&lt;/i&gt; Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers

Figure S2 from ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer

Supplemental Figure S2 from Nicotine Reduces Survival Via Augmentation of Paracrine HGF–MET Signaling in the Pancreatic Cancer Microenvironment

Supplementary Figure 4 from Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

Supplementary Figure 2 from PTEN Loss Accelerates <i>Kras</i><sup><i>G12D</i></sup>-Induced Pancreatic Cancer Development

Supplementary Figure S6 from HER2/EGFR–AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer

Supplementary Figure 7 from Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

Supplementary Figure 2 from <i>secreted Protein Acidic and Rich in Cysteines-like 1</i> Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers